[Influence of magnesium on rate of sodium transport through lymphocyte membranes in patients with hypertension].
Clinical and experimental investigations indicate that one of the causes of primary hypertension may be diminished membrane sodium efflux. Magnesium is thought to be one of necessary factors that influence normal sodium membrane efflux and thereby maintains correct membrane gradient and potential. The aim of the study was to determinate the influence of intravenous 25% magnesium sulphate infusion on arterial pressure and sodium leukocyte membrane efflux in subjects suffering from primary arterial hypertension. The measurements were performed in 43 hypertensive patients. All patients have been divided into two groups: first-23 subjects with mild hypertension (5 women aged 32 to 50 years and 18 men aged 22 to 58 years), second-20 subjects with moderate hypertension (7 women aged 41 to 60 years and 13 men aged 28 to 65 years). The control group consisted of 31 healthy volunteers (9 women aged 37 to 55 years and 22 men aged 21 to 60 years). After venous catheter has been placed in cephalic vein standard supine arterial pressure measurements and venous blood were obtained in every person. Infusion of 20 ml 25% magnesium sulphate dissolved in 500 ml 5% dextrose was administered during 60 minutes. Again measurements were obtained after the infusion all. Arterial blood pressure was also measured 6 hours after infusion. In our investigation we proved that infusion of 20.3 mmol. of magnesium in patients with primary hypertensive disease enhanced total and furosemide-dependent but not oubain-dependent sodium membrane efflux. It did not also influence neither systolic nor diastolic arterial pressure. The greatest enhancement of total and furosemide-dependent sodium membrane efflux was observed in persons who had the greatest enhancement of magnesium blood concentration.
Kucharski
W
W
Katedry i Kliniki Kardiologii Akademii Medycznej we Wroclawiu.
Salomon
P
P
D000328:Adult; D000368:Aged; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D002463:Cell Membrane Permeability / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000378:metabolism*; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology*; D008274:Magnesium / Q000494:pharmacology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D012964:Sodium / Q000378:metabolism*
D012964:Sodium; D008274:Magnesium
Wpływ magnezu na wskaźniki szybkości przepływu sodu przez błony komórkowe limfocytów u chorych na nadciśnienie tetnicze.